Abstract | OBJECTIVE: To study the biodistribution of purified CD133(+) cells after intracoronary injection in patients with stable chronic postinfarction heart failure. PATIENTS AND METHODS: Patients with longstanding myocardial infarction (>12 months prior to inclusion) and with an accessible left coronary artery were eligible. CD133(+) cells were mobilized with granulocyte colony-stimulating factor and purified with a CliniMACS device. Cells were labeled with (111) Indium and injected through a balloon catheter in a coronary artery feeding the necrotic or viable infarct-related region of the left ventricle during a standard coronary catheterization procedure. The total body biodistribution of (111) Indium was studied with a dual-head gamma camera in combination with (99m)Technetium-sestaMIBI cardiac distribution analysis. RESULTS: The number of CD133(+) cells injected ranged between 5 and 10 x 10(6) cells (low dose, three patients) or between 18.5 and 50 x 10(6) cells (high dose, five patients). In the five patients receiving the higher cell doses, a clear residual radioactivity was observed at the level of the chronic injury at 2, 12, and up to 36 hours after injection. A detailed analysis in two patients showed 6.9% to 8.0% (after 2 hours) and 2.3% to 3.2% (after 12 hours) residual radioactivity at the heart. No adverse events were observed during the procedure and up to 3 months follow-up. CONCLUSIONS: We demonstrate that CD133(+) progenitor cells are capable of homing to the postinfarction remodeling myocardium after intracoronary injections in patients with chronic postinfarction heart failure.
|
Authors | Rik Schots, Gilles De Keulenaer, Danny Schoors, Vicky Caveliers, Martine Dujardin, Stefan Verheye, Guy Van Camp, Philippe R Franken, Jan Roland, Ivan Van Riet, Hendrik Everaert |
Journal | Experimental hematology
(Exp Hematol)
Vol. 35
Issue 12
Pg. 1884-90
(Dec 2007)
ISSN: 0301-472X [Print] Netherlands |
PMID | 17923244
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- AC133 Antigen
- Antigens, CD
- Glycoproteins
- PROM1 protein, human
- Peptides
|
Topics |
- AC133 Antigen
- Aged
- Antigens, CD
(immunology)
- Chronic Disease
- Female
- Glycoproteins
(immunology)
- Heart Failure
(pathology)
- Humans
- Male
- Middle Aged
- Myocardial Infarction
(immunology, pathology)
- Myocardium
(pathology)
- Peptides
(immunology)
- Stem Cells
(cytology, immunology)
|